Zia Ullah: Hidden Cerebral Venous Sinus Thrombosis After Dengue Recovery
Zia Ullah, Ambassador at AxeUSCE and MetaSphere Global, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical Case Reports, adding:
”I am pleased to share the publication of our case report title ‘A Prothrombotic Shift: Cerebral Venous Sinus Thrombosis in the Recovery Phase of Dengue Fever-A Case Report’ in the journal Clinical Case Reports.
This case highlights a rare occurrence of cerebral venous sinus thrombosis during the recovery phase of dengue fever, underscoring the importance of maintaining clinical vigilance even after apparent recovery.
I am grateful to my all co-authors especially Zain Ul Abedeen for their valuable contributions to this work.”
Title: A Prothrombotic Shift: Cerebral Venous Sinus Thrombosis in the Recovery Phase of Dengue Fever-A Case Report
Authors: Zain Ul Abedeen, Waqar Khan, Waqar Iqbal Khan, Zia Ullah, Naeem Ullah, Abad Ur Rehman

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 11, 2026, 07:59Uday Sankar Akash Vankayala: Key Findings on IBD-Associated VTE Phenotypes and Inpatient Burden
-
Jun 11, 2026, 07:24Aaron Rodriguez Calienes: RESISTANT Registry Provides Reassuring Safety Data for Acute Intracranial Stenting
-
Jun 11, 2026, 07:17Mbunya. S. Misiani: From the WFH Congress to Meaningful Change for Patients with Bleeding Disorders Worldwide
-
Jun 11, 2026, 07:06Bernard Slater Jr.: Hemophilia B Reminds You that No Matter How Strong You Are, You Are Still Human
-
Jun 11, 2026, 05:11Daniel I McIsaac: Less Blood Loss and No Excess VTE with Tranexamic Acid in High-Risk Surgery
-
Jun 11, 2026, 05:03Aymeric Couturier: Lessons from the TRACK Trial on Anticoagulation in Advanced CKD
-
Jun 11, 2026, 04:53Umut Kocabas: Current Practice and Guideline Adherence on Cancer-Associated Thrombosis in Turkey
-
Jun 11, 2026, 04:40Fernanda Orsi: Which Obstetric APS Patients Are More Likely to Develop Thromboses?
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See